Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study.

Steenholdt, Casper; Molazahi, Akbar; Ainsworth, Mark Andrew; Brynskov, Jørn; Østergaard Thomsen, Ole; Seidelin, Jakob Benedict

Steenholdt, Casper; Molazahi, Akbar; Ainsworth, Mark Andrew; Brynskov, Jørn; Østergaard Thomsen, Ole; Seidelin, Jakob Benedict.

Affiliation

Steenholdt C; Dept of Gastroenterology, Herlev Hospital, Denmark. steenholdt@brygge.dk

Scand J Gastroenterol ; 47(5): 518-27, 2012 May.

Article in En | MEDLINE | ID: mdl-22375898

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Antibodies, Monoclonal/therapeutic use; Colitis, Ulcerative/drug therapy; Crohn Disease/drug therapy; Withholding Treatment; Adult; Confidence Intervals; Denmark; Female; Follow-Up Studies; Humans; Infliximab; Kaplan-Meier Estimate; Male; Odds Ratio; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Crohn Disease / Withholding Treatment / Anti-Inflammatory Agents / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Scand J Gastroenterol Year: 2012 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google